Page last updated: 2024-09-03

mci 154 and pindolol

mci 154 has been researched along with pindolol in 1 studies

Compound Research Comparison

Studies
(mci 154)
Trials
(mci 154)
Recent Studies (post-2010)
(mci 154)
Studies
(pindolol)
Trials
(pindolol)
Recent Studies (post-2010) (pindolol)
65103,71866292

Protein Interaction Comparison

ProteinTaxonomymci 154 (IC50)pindolol (IC50)
Beta-2 adrenergic receptorHomo sapiens (human)0.0005
Beta-1 adrenergic receptorHomo sapiens (human)0.0009
Beta-3 adrenergic receptorHomo sapiens (human)0.088
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.048
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)0.048

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endoh, M; Kitada, Y; Narimatsu, A; Suzuki, R; Taira, N1

Other Studies

1 other study(ies) available for mci 154 and pindolol

ArticleYear
Does the positive inotropic action of a novel cardiotonic agent, MCI-154, involve mechanisms other than cyclic AMP?
    The Journal of pharmacology and experimental therapeutics, 1987, Volume: 243, Issue:2

    Topics: Animals; Carbachol; Cardiotonic Agents; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Female; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Phosphoric Diester Hydrolases; Pindolol; Pyridazines; Reserpine; Stimulation, Chemical; Tetrodotoxin

1987